Tag Archive: B-cell precursor acute lymphoblastic leukemia

Aug 31 2017

A Moment to Remember: First-of-its-Kind Cancer Treatment Approved by FDA

It was a pivotal moment that has turned into a new era for cancer immunotherapy. On April 17, 2012, Children’s Hospital of Philadelphia researchers for the first time treated a pediatric patient with a cellular therapy that used her own reprogrammed immune cells, called T cells, to attack her aggressive form of blood cancer.

Permanent link to this article: http://blog.research.chop.edu/moment-remember-first-kind-cancer-treatment-approved-fda/